SCHEMBL9944908

SCHEMBL9944908

CNc1cc(N2CC3(CCC3)C2)c(C(=O)N[C@H]2CC[C@H](C)CC2)cc1[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
POLB P06746 1/20 0.40
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
TAS1R2 Q8TE23 1/20 0.36
PTGES O14684 1/20 0.35
MAPT P10636 5/20 0.34
KMT2A Q03164 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CTPS1 P17812 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944906 0.91 ALDH1A1 (0.42) ALDH1A1POLBNPC1RAB9ATAS1R3
SCHEMBL9944901 0.90 ALDH1A1 (0.41) ALDH1A1POLBNPC1RAB9ATAS1R3
SCHEMBL9944892 0.89 ALDH1A1 (0.42) ALDH1A1POLBNPC1RAB9ATAS1R3
SCHEMBL9944819 0.89 ALDH1A1 (0.41) ALDH1A1POLBNPC1RAB9ATAS1R3
SCHEMBL9944949 0.88 POLB (0.43) ALDH1A1POLBNPC1RAB9ATAS1R3
SCHEMBL9944912 0.87 POLB (0.51) ALDH1A1POLBNPC1RAB9ATAS1R3
SCHEMBL9944891 0.86 ALDH1A1 (0.41) ALDH1A1POLBNPC1RAB9ATAS1R3
SCHEMBL9944909 0.85 RAB9A (0.40) NPC1RAB9ATAS1R3TAS1R1TAS1R2
SCHEMBL9944746 0.85 POLB (0.39) ALDH1A1POLBNPC1RAB9ATAS1R3
SCHEMBL9944885 0.85 ALDH1A1 (0.44) ALDH1A1POLBNPC1RAB9ATAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885POLB 2315/4885NPC1 1695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.